ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

Freireich, Moertel Matched Up Again

February 20, 1981

Professional Societies: Tobacco Industry Should Pay For Research, AACR Says

August 15, 1997